Atenolol and Ponesimod: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Ponesimod
Atenolol
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can slow your heart rate, and together the effect can add up. Atenolol (Tenormin) is a beta-blocker that slows the heart. Ponesimod (Ponvory) for multiple sclerosis also tends to lower heart rate, especially in the first days when you are building up the dose. Used together, your heart could beat too slowly or skip beats, which might make you feel dizzy, tired, or faint.
The good news is this is very manageable. Do not stop or change either medicine on your own. Your care team will usually check your heart rate before starting ponesimod, and they may pause or adjust your atenolol and watch you closely during the start-up phase.
Additive negative chronotropic effect (PD interaction, not metabolic) between ponesimod, an S1P receptor modulator that transiently reduces heart rate during dose initiation/up-titration, and atenolol, a beta-1 antagonist. Concurrent use raises the risk of severe bradycardia and AV block, primarily at ponesimod initiation. Evidence is theoretical; severity rated major; onset tied to titration period.
- Assess resting HR before starting ponesimod; consult cardiology on monitoring.
- If chronic beta-blocker HR >55 bpm, ponesimod may be introduced.
- If HR ≤55 bpm, interrupt beta-blocker until baseline >55 bpm, then start ponesimod.
- A beta-blocker can be (re)initiated once ponesimod reaches target maintenance dose.
What happens
An increased risk of severe bradycardia and heart block
Interaction Deep Dive
Taking beta-blockers at the same time that ponesimod is being started may lead to severe bradycardia and heart block. For this reason, exercise caution when beginning ponesimod in patients already on beta-blocker therapy. It may be necessary to pause beta-blocker treatment temporarily before ponesimod is started. Conversely, beta-blocker therapy can be started in patients who are already on stable doses of ponesimod. When such treatment is being considered, obtain guidance from a cardiologist before starting therapy in order to establish the most suitable monitoring approach. In patients on a stable beta-blocker dose, ponesimod may be introduced provided that the resting heart rate exceeds 55 beats per minute (bpm) during chronic beta-blocker treatment. When the resting heart rate is 55 bpm or lower, the beta-blocker should be paused until the baseline heart rate rises above 55 bpm. Ponesimod can then be started, and the beta-blocker can be resumed once ponesimod has been up-titrated to the target maintenance dosage1.
Why it happens (mechanism)
Additive effects on lowering heart rate
How to manage this interaction
Keep taking both exactly as prescribed and let this be coordinated by your care team, not changed on your own.
- Your team will typically check your resting heart rate before starting ponesimod.
- Advice from a cardiologist may be sought to decide the right monitoring.
- If your heart rate is above 55 beats per minute on your beta-blocker, ponesimod can usually be started. If it is 55 or below, your team may temporarily pause atenolol until your rate recovers, then begin ponesimod.
- Atenolol can be restarted once ponesimod reaches its full maintenance dose.
Tell your pharmacist or prescriber about any dizziness, fainting, or a very slow pulse.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In a study evaluating drug-drug interactions, the ponesimod dose titration schedule was given to subjects who were receiving propranolol 80 mg once daily at steady state. No meaningful changes were seen in the pharmacokinetics of either ponesimod or propranolol. Relative to ponesimod given by itself, combining propranolol with the initial ponesimod dose (2 mg) produced a mean hourly heart rate reduction of 12.4 beats per minute (90% CI, -15.6 to -9.1). Relative to ponesimod alone, propranolol given together with the first maintenance dose of ponesimod (20 mg) produced a mean hourly heart rate reduction of 7.4 beats per minute (90% CI, -10.9 to -3.9) 1.
Common questions
Can I take Atenolol and Ponesimod together?
Ponesimod and atenolol both slow the heart, so combining them can cause dangerously slow heartbeat or heart block, mainly when ponesimod is being started. Your care team can manage this safely by checking your heart rate and adjusting timing, so do not change either drug on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Atenolol and Ponesimod interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Atenolol and Ponesimod interaction managed?
Keep taking both exactly as prescribed and let this be coordinated by your care team, not changed on your own. Your team will typically check your resting heart rate before starting ponesimod. Advice from a cardiologist may be sought to decide the right monitoring. If your heart rate is above 55 beats per minute on your beta-blocker, ponesimod can usually be started. If it is 55 or below, your tea… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Atenolol or Ponesimod need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: PONVORY(R) oral tablets, ponesimod oral tablets. Janssen Pharmaceuticals Inc (per FDA), Titusville, NJ, 2024. DailyMed
Keep reading about Ponesimod
Keep reading about Atenolol
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist